1887

Abstract

Existing assays to detect antibodies to human papillomavirus type 16 (HPV-16) proteins in sera from cervical carcinoma patients rely primarily on bacterially produced recombinant proteins or synthetic peptides for use as target antigens. These methods have had limited success in the detection of antibodies against the E6 protein. To produce more authentic E6 protein for use in serological assays, we have employed a recombinant baculovirus vector to synthesize the protein in insect cells. Cells infected with the vector containing E6 gene sequences expressed a stable protein doublet comprising 18.5K and 19.1K bands. This protein reacted in Western blots with an anti-serum raised against a purified E6 fusion protein produced in . This antiserum, and several others raised against -derived E6 fusion proteins, were unable to recognize the baculovirus E6 protein in radioimmunoprecipitation assays (RIPAs). However, serum from a cervical carcinoma patient readily immunoprecipitated the baculovirus E6 protein, suggesting that the baculovirus-derived protein represented a realistic antigenic target. A RIPA was developed for the detection of anti-E6 protein antibodies in human sera. The assay was tested on a selected group of sera from carcinoma patients and controls, in comparison with a Western blotting method using bacterial fusion proteins. The baculovirus E6 protein-based RIPA showed a marked increase in detection rate over the Western blotting method. These findings suggest that serum antibodies to HPV-16 E6 protein may be more prevalent than has previously been shown.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-9-2337
1992-09-01
2021-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/9/JV0730092337.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-9-2337&mimeType=html&fmt=ahah

References

  1. Androphy E. J., Hubbert N. L., Schiller J. T., Lowy D. R. 1987; Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO Journal 6:989–992
    [Google Scholar]
  2. Bailey M. J., Possee R. D. 1991; Manipulation of baculovirus vectors. In Methods in Molecular Biology vol 7 pp 147–168 Edited by Murray E. J. Clifton, New Jersey: The Humana Press;
    [Google Scholar]
  3. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M. 1987; Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. Journal of Virology 61:962–971
    [Google Scholar]
  4. Banks L., Spence P., Androphy E., Hubbert N., Matlashewski G., Murray A., Crawford L. 1987; Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. Journal of General Virology 68:1351–1359
    [Google Scholar]
  5. Banks L., Moreau F., Vousden K., Pim D., Matlashewski G. 1991; Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages. Journal of Immunology 146:2037–2042
    [Google Scholar]
  6. Barbosa M. S., Lowy D. R., Schiller J. T. 1989; Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. Journal of Virology 63:1404–140
    [Google Scholar]
  7. Bonnez W., Rose R. C., Reichman R. C., Strike D. G. 1990; The Pst I–Xho II restriction fragment of the HPV-6b L1 ORF lacks immunological specificity as determined by sera from HPV-6 condyloma acuminatum patients and controls. In UCLA Symposia on Molecular and Cellular Biology, New Series vol 124 pp 77–80 Edited by Howley P., Broker T. New York: Allan R. Liss;
    [Google Scholar]
  8. Bonnez W., Da Rin C., Rose R. C., Reichman R. C. 1991; Use of human papillomavirus type 11 virions in ELISA to detect specific antibodies in humans with condylomata acuminata. Journal of General Virology 72:1343–1347
    [Google Scholar]
  9. Cason J., Kambo P. K., Best J. M., McCance D. J. 1992; Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children. International Journal of Cancer 50:349–355
    [Google Scholar]
  10. Chen L., Kinney-Thomas E., Hu S.-L., Hellstrom I., Hellstrom K. E. 1991; Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proceedings of the National Academy of Sciences, U.S.A. 88:110–114
    [Google Scholar]
  11. Christensen N. D., Kreider J. W., Cladel N. M., Galloway D. M. 1990; Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins. Virology 175:1–9
    [Google Scholar]
  12. Comerford S. A., McCance D. J., Dougan G., Tite J. P. 1991; Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16. Journal of Virology 65:4681–4690
    [Google Scholar]
  13. Connor M. E., Stern P. L. 1990; Loss of MHC class-I expression in cervical carcinomas. International Journal of Cancer 46:1029–1034
    [Google Scholar]
  14. Cowsert L. M., Lake P., Jenson A. B. 1987; Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. Journal of the National Cancer Institute 79:1053–1057
    [Google Scholar]
  15. Dillner J. 1990; Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. International Journal of Cancer 46:703–711
    [Google Scholar]
  16. DiMaio D. 1991; Transforming activity of bovine and human papillomaviruses in cultured cells. Advances in Cancer Research 56:133–159
    [Google Scholar]
  17. Dyson N., Howley P. M., Munger K., Harlow E. 1989; The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937
    [Google Scholar]
  18. Fung M. C., Chiu K. Y., Weber T., Chang T. W., Chang N. T. 1988; Detection and purification of a recombinant human B lymphotropic virus (HHV-6) in the baculovirus expression system by limiting dilution and DNA dot-blot hybridization. Journal of Virological Methods 19:33–42
    [Google Scholar]
  19. Galloway D. A., McDougall J. K. 1989; Human papillomaviruses and carcinomas. Advances in Virus Research 37:125–171
    [Google Scholar]
  20. Grossman S. R., Laimins L. A. 1989; E6 protein of human papillomavirus type 18 binds zinc. Oncogene 4:1089–1093
    [Google Scholar]
  21. Jenison S. A., Firzlaff J. M., Langenberg A., Galloway D. A. 1988; Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. Journal of Virology 62:2115–2123
    [Google Scholar]
  22. Jochmus-Kudielka I., Schneider A., Braun R., Kimming R., Koldovsky U., Schneweis K. E., Seedorf K., Gissmann L. 1988; Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. Journal of the National Cancer Institute 81:1698–1703
    [Google Scholar]
  23. Kochel H. G., Sievert K., Monazahian M., Mittelstadt-Deterding A., Teichmann A., Thomssen R. 1991; Antibodies to human papillomavirus type 16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology 182:644–654
    [Google Scholar]
  24. Krchňák V., Vágner J., Suchánková A., Krčmář M., Ritterová L., Vonka V. 1990; Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. Journal of General Virology 71:2719–2724
    [Google Scholar]
  25. Lim P. S., Jenson A. B., Cowsert L., Nakai Y., Lim L. Y., Jin X. W., Sundberg J. P. 1990; Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. Journal of Infectious Diseases 162:1263–1269
    [Google Scholar]
  26. Mann V. M., Loo de Lao S., Brenes M., Brinton L. A., Rawls J. A., Green M., Reeves W. C., Rawls W. E. 1990; Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Research 50:7815–7819
    [Google Scholar]
  27. Matlashewski G. 1989; The cell biology of human papillomavirus transformed cells. Anticancer Research 9:1447–1556
    [Google Scholar]
  28. Meneguzzi G., Cerni C., Kieny M. P., Lathe R. 1991; Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology 181:62–69
    [Google Scholar]
  29. Munger K., Werness B. A., Dyson N., Phelps W. C., Harlow E., Howley P. M. 1989; Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO Journal 8:4099–4105
    [Google Scholar]
  30. Niedobitek G., Herbst H. 1991; Human papillomaviruses and cancer. Cancer Journal 4:163–167
    [Google Scholar]
  31. Page M. J. 1989 p36C: an improved baculovirus expression vector for producing high levels of mature recombinant proteins.. Nucleic Acids Research 17:454
    [Google Scholar]
  32. Pfister H. 1987; Human papillomaviruses and genital cancer. Advances in Cancer Research 48:113–147
    [Google Scholar]
  33. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  34. Schneider-Gadicke A., Schwarz E. 1986; Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO Journal 5:2285–2292
    [Google Scholar]
  35. Schneider-Gadicke A., Kaul S., Schwarz E., Gausepohl H., Frank R., Bastert G. 1988; Identification of the human papillomavirus type 18 E6* and E6 proteins in nuclear protein fractionations from human cervical carcinoma cells grown in the nude mouse or in vitro . Cancer Research 48:2969–2974
    [Google Scholar]
  36. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature, London 314:111–114
    [Google Scholar]
  37. Seedorf K., Krammer G., Durst M., Suhai S., Rowenkamp W. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
    [Google Scholar]
  38. Seedorf K., Oltersdorf T., Krammer G., Rowekamp W. 1987; Identification of early proteins of the human papillomaviruses type 16 (HPV-16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO Journal 6:139–144
    [Google Scholar]
  39. Smotkin D., Wettstein F. O. 1986; Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer derived cell line and identification of the E7 protein. Proceedings of the National Academy of Sciences, U.S.A. 83:4680–4684
    [Google Scholar]
  40. Strang G., Hickling J. K., McIndoe G. A. J., Howland K., Wilkinson D., Ikeda H., Rothbard J. B. 1990; Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. Journal of General Virology 71:423–431
    [Google Scholar]
  41. Strike D. G., Bonnez W., Rose R. C., Reichman R. C. 1989; Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the ‘common antigen’ region. Journal of General Virology 70:543–555
    [Google Scholar]
  42. Summers M. D., Smith G. E. 1987 A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures Texas Agricultural Experimental Station, Texas A & M University; Texas:
    [Google Scholar]
  43. Vousden K. H. 1989; Human papillomaviruses and cervical carcinoma. Cancer Cells 1:43–50
    [Google Scholar]
  44. Werness B. A., Levine A. J., Howley P. M. 1990; Association of human papillomaviruses types 16 and 18 E6 proteins with p53. Science 248:76–19
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-9-2337
Loading
/content/journal/jgv/10.1099/0022-1317-73-9-2337
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error